Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral montelukast for control of acute asthma attacks in children
IRCT20220508054776N1Phase 3Completed
- Sponsor
- Qom University of Medical Sciences
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of montelukast in asthma, sponsored by Qom University of Medical Sciences. Started Feb 2024; status: completed.
02
Drugs
montelukast
03
Conditions
asthma
Beyond the preview
Go deeper on IRCT20220508054776N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220508054776N1.